DURECT Corporation (DRRX)
NASDAQ: DRRX · Real-Time Price · USD
0.8000
-0.0060 (-0.74%)
At close: Mar 28, 2025, 4:00 PM
0.7949
-0.0051 (-0.64%)
After-hours: Mar 28, 2025, 7:55 PM EDT
DURECT Employees
DURECT had 58 employees as of December 31, 2023. The number of employees decreased by 21 or -26.58% compared to the previous year.
Employees
58
Change (1Y)
-21
Growth (1Y)
-26.58%
Revenue / Employee
$35,017
Profits / Employee
-$135,759
Market Cap
24.83M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DRRX News
- 4 days ago - DURECT Corporation (DRRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 days ago - DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - PRNewsWire
- 11 days ago - DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update - PRNewsWire
- 7 weeks ago - DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire
- 2 months ago - DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence - PRNewsWire
- 4 months ago - DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million - PRNewsWire
- 4 months ago - DURECT Corporation (DRRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update - PRNewsWire